What We Do
The Medical Writing Partner Your Team Has Been Looking For
The documents that support your development program do more than satisfy regulatory requirements. They communicate your science, inform critical decisions, and help advance your product from first-in-human studies through marketing application submissions.
At Eldridge Writing, we provide high-touch medical writing leadership across the clinical development lifecycle. Beyond document authoring, we guide planning, coordination, and execution so the process stays organized, focused, and aligned with strategic goals. As we remain engaged across milestones, every deliverable benefits from our increasing understanding of your science, strategy, and ways of working.
Our writers have supported programs across a broad range of therapeutic areas, including dermatology, gene therapy, hematology/oncology, hepatology, immunology, neurology, ophthalmology, pulmonology, rare disease, and more.
Marketing Application Submissions
Marketing application submissions represent the culmination of years of clinical development, and each component must contribute to a cohesive evidence narrative. Clinical Overviews (Module 2.5) and Clinical Summaries (Module 2.7) demand a deep understanding of the science, development history, and evidence supporting the benefit-risk profile of your product.
Eldridge Writing provides medical writing leadership for New Drug Applications (NDAs), Biologics License Applications (BLAs), and Marketing Authorisation Applications (MAAs). We help teams prepare well-supported submission documents that convey the full clinical context and reflect the strength of the underlying data.
Alignment matters, and we ensure that key messages, data interpretation, and clinical positioning remain cohesive across documents. The result is a more integrated submission package, greater efficiency, and polished deliverables that are ready for focused review.
Clinical Overview (Module 2.5)
The Clinical Overview brings together years of development into a concise, science-driven narrative. Drawing on a deep understanding of your product, data, and development history, we craft overviews that contextualize the clinical evidence and connect key messages across the submission.
Summary of Clinical Efficacy (Module 2.7.3)
Presenting efficacy data effectively requires more than reporting results. We work closely with clinical, biostatistics, and regulatory stakeholders to develop summaries that synthesize the totality of the evidence, align presentation across studies, and connect to the broader submission narrative.
Summary of Clinical Safety (Module 2.7.4)
A strong safety summary presents the safety data in a structured, scientifically grounded way, while maintaining consistency across studies and submission components. We develop well-organized, participant-focused summaries that synthesize program-wide safety findings to inform the product’s risk profile.
Integrated Summary of Safety (ISS) and Integrated Summary of Effectiveness (ISE)
The ISS and ISE bring together extensive data across studies to support a comprehensive understanding of effectiveness and safety. We develop integrated summaries that are scientifically rigorous, internally consistent, and clearly aligned with the broader clinical narrative, helping teams communicate complex findings with clarity and confidence.
Clinical Study Documentation
Well-developed clinical study documents support informed decision-making, effective study execution, and reliable communication of study results. They provide the foundation for successful development programs, connecting study objectives, operational execution, and clinical evidence throughout development. Whether preparing for study start-up, managing protocol changes, or communicating study results, we bring clarity, accuracy, and continuity to your clinical deliverables.
Clinical Study Protocols and Amendments
Protocols are the foundation for study conduct, data collection, and clinical decision-making. We write well-organized protocols to align operational, clinical, and scientific objectives. When changes are needed, we develop protocol amendments efficiently and thoughtfully, helping teams adapt to evolving program needs while balancing timelines and quality.
Clinical Study Reports (CSRs)
CSRs communicate individual study results and support future development activities and submissions. We combine rigorous independent data interpretation and close cross-functional collaboration to develop clear, accurate CSRs that faithfully represent study findings and support downstream regulatory activities and future development milestones.
Investigator’s Brochures (IBs)
IBs are a central source of information throughout development. We develop and maintain IBs that synthesize clinical and nonclinical information into a scientifically sound resource for investigators, ethics committees, and study teams. As programs evolve, we ensure IBs are aligned with the latest available clinical and nonclinical evidence and benefit-risk analysis.
Regulatory Agency Interactions
Regulatory interactions are important opportunities to communicate the science, development plan, and evidence supporting the next steps for your program. We help teams prepare strategic, well-organized documents that facilitate productive communication with regulatory agencies.
Briefing Documents and Meeting Packages
From FDA Type A, B, C, and D meetings to EMA Scientific Advice procedures, we develop briefing documents that articulate the scientific context, Sponsor’s positions, and supporting data to prepare for meaningful regulatory interactions.
Responses to Regulatory Information Requests
When agencies request additional information, clear and timely responses are critical. We work closely with cross-functional teams to develop organized, well-supported responses that address questions directly, maintain consistency across the development program, and facilitate efficient review.
Special Designation Applications
Breakthrough Therapy, Fast Track, Orphan Drug, and other special designation programs provide opportunities to accelerate development, enhance regulatory interactions, and support advancement of promising therapies. We develop special designation applications that present the available evidence and rationale supporting eligibility, helping sponsors build a complete and well-organized case aligned with the applicable criteria.
Safety and Pharmacovigilance Writing
Accurate and timely safety documentation protects patients, meets regulatory obligations, and supports the integrity of your clinical program. We provide high-quality safety and pharmacovigilance writing to help your team communicate evolving safety information throughout the clinical development lifecycle.
Development Safety Update Reports (DSURs)
DSURs provide regulators with an annual assessment of a product’s evolving safety profile. We develop DSURs that synthesize safety information across the development program, helping sponsors meet reporting requirements and maintain alignment across program-level safety communications.
Patient Narratives
Patient narratives communicate important safety events through the experience of individual trial participants. We develop narratives that accurately characterize key safety events while providing the clinical context needed to support safety evaluation and regulatory reporting.
Ongoing Safety Documentation
Effective safety oversight depends on timely communication. From safety review committee presentations to interim safety analyses and other ongoing safety deliverables, we help teams develop documentation that supports informed decision-making throughout the clinical development lifecycle.
Medical Writing Leadership & Program Support
Successful documents depend on more than strong writing. Planning, coordination, review management, and quality oversight shape how efficiently and effectively documents move from kickoff to completion. We provide high-touch medical writing leadership that reduces friction, builds alignment, and keeps critical deliverables moving from kickoff through completion.
Document Planning & Execution
We help teams plan and execute document development activities across key milestones, identifying deliverables, dependencies, and timelines to support efficient, well-coordinated execution.
Document Shells & First Draft Authoring
We develop document shells and first drafts that establish a strong foundation, align contributors early, and support efficient cross-functional collaboration.
Timeline Development & Management
We create pragmatic timelines that account for review cycles, comment resolution, quality reviews, and key development milestones, helping teams maintain momentum and visibility throughout the process.
Meeting Facilitation & Comment Adjudication
We facilitate kickoff meetings, working sessions, and comment adjudication meetings that help align stakeholders and resolve issues efficiently.
Review Management & Quality Control
We coordinate review activities, manage comment incorporation across drafts, and apply rigorous quality control processes to promote consistency, accuracy, and submission-readiness.
Why Teams Partner with Us
Sustained Knowledge. Stronger Deliverables.
The strongest medical writing partnerships are built on trust. As programs progress, continuity preserves knowledge, strengthens collaboration, and improves efficiency.
Expertise That Stays With Your Program
Our team takes the time to understand your science, regulatory history, development plan, and ways of working, and we carry that knowledge from one milestone to the next. As we build relationships with your team and earn your trust, document development becomes more efficient, collaboration becomes smoother, and the value we provide grows beyond any single deliverable.
Trusted Judgment & Dependable Execution
Our writers bring broad experience across clinical and regulatory document types, combined with the scientific expertise needed to support complex programs. We’re thoughtful in our approach and deliver drafts that enable focused reviews when it matters most.
A Connected Team with Built-in Resilience
We operate as a collaborative team with shared standards for quality and client service. This model provides continuity, scalable support, and the flexibility to adapt as programs evolve, helping ensure documents remain on track without sacrificing quality.
Responsive Partnership
Clinical development rarely follows a predictable path. Priorities shift, timelines change, and new challenges emerge. We work alongside our clients to adapt efficiently, maintain momentum, and support evolving program needs.
Unwavering Commitment to Quality
Quality is more than a final review step. We build it into every phase of document development, from planning and authoring through review and finalization.